AIM
Price
$0.22
Change
-$0.01 (-4.35%)
Updated
Sep 11 closing price
Capitalization
8.3M
66 days until earnings call
Intraday BUY SELL Signals
BRTX
Price
$2.67
Change
-$0.09 (-3.26%)
Updated
Sep 11 closing price
Capitalization
3.63M
67 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AIM vs BRTX

AIM vs BRTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AIM vs. BRTX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and BRTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AIM($8.3M) has a higher market cap than BRTX($3.63M). AIM YTD gains are higher at: -80.361 vs. BRTX (-88.638). AIM has higher annual earnings (EBITDA): -12.7M vs. BRTX (-14.01M). BRTX has more cash in the bank: 17.9M vs. AIM (9.96M). BRTX has less debt than AIM: BRTX (0) vs AIM (3.92M). BRTX has higher revenues than AIM: BRTX (358K) vs AIM (95K).
AIMBRTXAIM / BRTX
Capitalization8.3M3.63M228%
EBITDA-12.7M-14.01M91%
Gain YTD-80.361-88.63891%
P/E RatioN/AN/A-
Revenue95K358K27%
Total Cash9.96M17.9M56%
Total Debt3.92M0-
FUNDAMENTALS RATINGS
AIM vs BRTX: Fundamental Ratings
AIM
BRTX
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9194
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRTX's Valuation (14) in the null industry is in the same range as AIM (16). This means that BRTX’s stock grew similarly to AIM’s over the last 12 months.

BRTX's Profit vs Risk Rating (100) in the null industry is in the same range as AIM (100). This means that BRTX’s stock grew similarly to AIM’s over the last 12 months.

BRTX's SMR Rating (100) in the null industry is in the same range as AIM (100). This means that BRTX’s stock grew similarly to AIM’s over the last 12 months.

AIM's Price Growth Rating (91) in the null industry is in the same range as BRTX (94). This means that AIM’s stock grew similarly to BRTX’s over the last 12 months.

AIM's P/E Growth Rating (100) in the null industry is in the same range as BRTX (100). This means that AIM’s stock grew similarly to BRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMBRTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 24 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 2 days ago
88%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (AIM: $0.22 vs. BRTX: $2.67)
Brand notoriety: AIM and BRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 55% vs. BRTX: 1%
Market capitalization -- AIM: $8.3M vs. BRTX: $3.63M
AIM [@Biotechnology] is valued at $8.3M. BRTX’s [@Biotechnology] market capitalization is $3.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 1 FA rating(s) are green while BRTX’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 1 green, 4 red.
  • BRTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both AIM and BRTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 3 TA indicator(s) are bullish while BRTX’s TA Score has 4 bullish TA indicator(s).

  • AIM’s TA Score: 3 bullish, 4 bearish.
  • BRTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AIM is a better buy in the short-term than BRTX.

Price Growth

AIM (@Biotechnology) experienced а -2.59% price change this week, while BRTX (@Biotechnology) price change was -95.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

AIM is expected to report earnings on Nov 17, 2026.

BRTX is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AIM
Daily Signal:
Gain/Loss:
BRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKIN0.700.01
+1.45%
SkinHealth Systems Inc.
VTEX3.600.05
+1.41%
VTEX
CLH322.821.88
+0.59%
Clean Harbors
FEED3.580.01
+0.28%
ENvue Medical
MGEE76.480.04
+0.05%
MGE Energy

AIM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AIM has been loosely correlated with URGN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AIM jumps, then URGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIM
1D Price
Change %
AIM100%
-2.29%
URGN - AIM
39%
Loosely correlated
+0.17%
RKTO - AIM
33%
Loosely correlated
-0.73%
RLYB - AIM
30%
Poorly correlated
+0.75%
SGMT - AIM
30%
Poorly correlated
-1.63%
LEGN - AIM
28%
Poorly correlated
-2.87%
More

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
-3.26%
TCRT - BRTX
33%
Loosely correlated
-1.32%
EDIT - BRTX
30%
Poorly correlated
+1.89%
MCRB - BRTX
30%
Poorly correlated
-1.76%
GRCE - BRTX
28%
Poorly correlated
-1.77%
AIM - BRTX
27%
Poorly correlated
-2.29%
More